Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick A Bright

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
JAMA|May 10, 2022
Testing, Surveillance, and Mitigation Strategies for COVID-19-ReplyEzekiel J Emanuel, David Michaels, Rick A Bright
JAMA|January 6, 2022
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and TherapeuticsLuciana L Borio, Rick A Bright, Ezekiel J Emanuel
The Lancet. Global Health|August 17, 2023
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threatsStefano Ongarello, Daniel G Bausch, Emma Hannay, et al.
Vaccine|October 21, 2009
WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008Rick A Bright, Kathleen M Neuzil, Yuri Pervikov, et al.
Scientific Reports|December 5, 2025
The AMR Knowledge Space Game: participatory modeling to address the complexity of antimicrobial resistanceFrancesca de Rosa, Alayna Wilson, Vittoria Seremedi Migliorini, et al.
Vaccine|January 28, 2003
Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteinsJudy A Mitchell, Thomas D Green, Rick A Bright, et al.
Lancet (London, England)|September 23, 2024
Changing the culture of blood cultureSally Davies, Richard A Marfuggi, Rick A Bright, et al.
Virology|April 23, 2003
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccineRick A Bright, Ted M Ross, Kanta Subbarao, et al.
JAMA|February 4, 2006
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United StatesRick A Bright, David K Shay, Bo Shu, et al.
Expert Review of Vaccines|September 26, 2012
PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countriesKathleen M Neuzil, Vadim Tsvetnitsky, Linda J Nyari, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
JAMA|May 10, 2022
Testing, Surveillance, and Mitigation Strategies for COVID-19-ReplyEzekiel J Emanuel, David Michaels, Rick A Bright
JAMA|January 6, 2022
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and TherapeuticsLuciana L Borio, Rick A Bright, Ezekiel J Emanuel
The Lancet. Global Health|August 17, 2023
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threatsStefano Ongarello, Daniel G Bausch, Emma Hannay, et al.
Vaccine|October 21, 2009
WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008Rick A Bright, Kathleen M Neuzil, Yuri Pervikov, et al.
Scientific Reports|December 5, 2025
The AMR Knowledge Space Game: participatory modeling to address the complexity of antimicrobial resistanceFrancesca de Rosa, Alayna Wilson, Vittoria Seremedi Migliorini, et al.
Vaccine|January 28, 2003
Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteinsJudy A Mitchell, Thomas D Green, Rick A Bright, et al.
Lancet (London, England)|September 23, 2024
Changing the culture of blood cultureSally Davies, Richard A Marfuggi, Rick A Bright, et al.
Virology|April 23, 2003
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccineRick A Bright, Ted M Ross, Kanta Subbarao, et al.
JAMA|February 4, 2006
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United StatesRick A Bright, David K Shay, Bo Shu, et al.
Expert Review of Vaccines|September 26, 2012
PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countriesKathleen M Neuzil, Vadim Tsvetnitsky, Linda J Nyari, et al.
Pageof 5